These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11377035)
41. Identification and structural characterization of four novel degradation products and a process impurity of isavuconazonium sulfate for injection formulation bulk by LC-ESI-QTOF-MS/MS. Regella VRPS; Subramanian VC; Bhetanabhotla SS Eur J Mass Spectrom (Chichester); 2020 Apr; 26(2):144-152. PubMed ID: 31707848 [No Abstract] [Full Text] [Related]
42. Development and Validation of a LC-MS/MS Method for the Profiling of Impurities Formed during Stress Study of Antifungal Agent-Efinaconazole. Govindarajan S; Asharani IV J Chromatogr Sci; 2022 Apr; 60(4):324-335. PubMed ID: 34160008 [TBL] [Abstract][Full Text] [Related]
43. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents. Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067 [TBL] [Abstract][Full Text] [Related]
44. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride. Bansal G; Singh M; Jindal KC; Singh S J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934 [TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method. Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336 [TBL] [Abstract][Full Text] [Related]
46. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS. Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334 [TBL] [Abstract][Full Text] [Related]
49. Impurity Profile of Bronchodilators used in Asthma: A Critical Review. Prajapati KJ; Kothari CS Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855 [TBL] [Abstract][Full Text] [Related]
50. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments. Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963 [TBL] [Abstract][Full Text] [Related]
51. Characterization of degradation products of idarubicin through LC-UV, MS(n) and LC-MS-TOF studies. Kaushik D; Bansal G J Pharm Biomed Anal; 2013 Nov; 85():123-31. PubMed ID: 23933565 [TBL] [Abstract][Full Text] [Related]
52. Study on the forced degradation behaviour of ledipasvir: Identification of major degradation products using LC-QTOF-MS/MS and NMR. Swain D; Samanthula G J Pharm Biomed Anal; 2017 May; 138():29-42. PubMed ID: 28171790 [TBL] [Abstract][Full Text] [Related]
53. Characterization of four new photodegradation products of hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF studies. Saini B; Bansal G J Pharm Biomed Anal; 2013 Oct; 84():224-31. PubMed ID: 23850938 [TBL] [Abstract][Full Text] [Related]
54. Identification and characterization of stress degradants of lacosamide by LC-MS and ESI-Q-TOF-MS/MS: development and validation of a stability indicating RP-HPLC method. Ramisetti NR; Kuntamukkala R; Lakshetti S; Sripadi P J Pharm Biomed Anal; 2014 Jul; 95():256-64. PubMed ID: 24699370 [TBL] [Abstract][Full Text] [Related]
55. Investigation of low-abundant in vitro metabolites of stable isotope-labelled BAL4815 by accurate mass capillary-LC-ESI-qTof-MS and MS/MS. Wind M; Spickermann J; Schleimer M; Donzelli M; Gebhardt K; Sturm-Haurany R; Klauer D; Fullhardt P; Schmitt-Hoffmann A J Mass Spectrom; 2006 Jul; 41(7):903-10. PubMed ID: 16810647 [TBL] [Abstract][Full Text] [Related]
56. Characterization of clinafloxacin photodegradation products by LC-MS/MS and NMR. Lovdahl MJ; Priebe SR J Pharm Biomed Anal; 2000 Aug; 23(2-3):521-34. PubMed ID: 10933546 [TBL] [Abstract][Full Text] [Related]
57. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction. Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899 [TBL] [Abstract][Full Text] [Related]
58. Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion. Wu Y; Hwang TL; Algayer K; Xu W; Wang H; Procopio A; DeBusi L; Yang CY; Matuszewska B J Pharm Biomed Anal; 2003 Dec; 33(5):999-1015. PubMed ID: 14656591 [TBL] [Abstract][Full Text] [Related]
59. Novel identification of a sulfur-centered, radical-derived 5,5-dimethyl-1-pyrroline N-oxide nitrone adduct formed from the oxidation of DTT by LC/ELISA, LC/electrospray ionization-MS, and LC/tandem MS. Guo Q; Gao G; Qian SY; Mason RP Chem Res Toxicol; 2004 Nov; 17(11):1481-90. PubMed ID: 15540946 [TBL] [Abstract][Full Text] [Related]
60. LC-MS/TOF, LC-MSn, on-line H/D exchange and LC-NMR studies on rosuvastatin degradation and in silico determination of toxicity of its degradation products: a comprehensive approach during drug development. Shah RP; Sahu A; Singh S Anal Bioanal Chem; 2013 Apr; 405(10):3215-31. PubMed ID: 23386001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]